Understanding Your Medical Test: A Patient's Guide to What It Is, Why It Is Done, and What Your Results Mean
This test detects IgA antibodies against Borrelia burgdorferi, the bacterium that causes Lyme disease, using immunofluorescence methods in a blood sample.
{"This test checks for IgA antibodies to Lyme disease bacteria in your blood","It helps diagnose Lyme disease, especially in early or late stages","Results are often combined with other Lyme disease tests for accuracy","A positive result suggests exposure to Lyme disease bacteria","Testing is typically done 2-4 weeks after potential tick exposure"}
Key facts at a glance
- LOINC
- 45165-8
- Short code
- Bb-IgA-IFA
- Synonyms
- B burgdor IgA Ser IF-aCnc
- Category
- chemistry
- Sample
- serum
- Container
- Serum separator tube (SST) or red-top tube without anticoagulant
- Units
- N/A
- Ref low
- 40
- Ref high
- 1
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- Immunofluorescence Assay (IFA)
- CPT
- 86618
- SNOMED
- 442740009
- Specimen volume
- 1-2 mL serum
- Stability
- Serum stable at room temperature for 8 hours; refrigerated at 2-8°C for 7 days; frozen at -20°C or below for up to 30 days. Avoid repeated freeze-thaw cycles.
- Hemolysis max
- 100
- Lipemia max
- 100
- Icterus max
- 50
- TAT
- 24–72 hours
- Order
- routine
What is this test? This test is a laboratory examination that measures specific substances in a sample of your blood, urine, or other body fluid. It helps your healthcare provider learn how your body is functioning and whether there are any signs of a medical condition that may need further evaluation, monitoring, or treatment.
The Borrelia burgdorferi IgA Antibody test is a blood test that looks for IgA antibodies specifically directed against Borrelia burgdorferi, the bacterium transmitted by black-legged ticks that causes Lyme disease. The test uses a laboratory method called immunofluorescence to detect these antibodies in your serum (the clear liquid part of your blood).
Why is this test performed? Your doctor may order this test to help diagnose a health problem, to screen for early signs of disease before symptoms develop, to monitor a condition you already have, or to check how well a treatment is working over time. The results provide important information that guides decisions about your ongoing care.
This test is primarily used to help diagnose Lyme disease. IgA antibodies typically appear earlier than IgG antibodies in Lyme disease infection (usually 2-4 weeks after the tick bite). Your healthcare provider may order this test if you have symptoms of Lyme disease such as a bull's-eye rash (erythema migrans), fever, headache, fatigue, or joint pain, especially if you have been in an area where Lyme disease is common.
How is the test done? The test is usually done by collecting a small sample in a clinic, hospital, or laboratory. For a blood sample, a trained professional cleans your skin, inserts a thin needle into a vein in your arm, and collects the sample into a tube. The procedure takes only a few minutes, and most people can return to their normal activities right away.
A healthcare professional will draw a small blood sample from a vein in your arm. This sample is then sent to a laboratory where technicians will use immunofluorescence techniques to detect any IgA antibodies against Borrelia burgdorferi. The test does not require any special preparation, but you should tell your healthcare provider about any medications or supplements you are taking.
Understanding your results: Your values are compared with established reference ranges to see whether they fall within the expected limits. A result that is higher or lower than normal does not always mean you have a serious illness, so your healthcare provider will interpret it together with your symptoms, medical history, and other test findings before recommending any next steps.
Test results are typically reported as positive, negative, or equivocal (unclear). A positive result indicates that IgA antibodies to Borrelia burgdorferi were detected in your blood, suggesting recent or past exposure to the Lyme disease bacteria. A negative result means no IgA antibodies were detected, which could mean you do not have Lyme disease, or the test was done too early before antibodies developed. An equivocal result may require repeat testing. Your healthcare provider will interpret these results in context with your symptoms, exposure history, and possibly other Lyme disease tests.
Reference range
Negative: <1:40 titer; Equivocal: 1:40-1:80; Positive: >1:80. Reference values may vary by laboratory.N/A
No special preparation required. Patient should inform clinician of recent antibiotic use, current immunosuppressive therapy, or recent vaccination, as these may affect antibody response.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
◆Associated findings1
Frequently asked questions
Do I need to fast before this test?
How long does it take to get results?
Can this test tell me if I have active Lyme disease?
Do I need to stop taking antibiotics before this test?
Is one test enough to diagnose Lyme disease?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 15, 2026. · Read our editorial policy